🟢 Immunitybio is trading 5.6% up today on biotech-sector strength

Immunitybio is trading at $8.15, up 5.63%, as strength across the biotechnology sector lifts sentiment.

• XBI is up 3.73% during regular trading after positive Moderna-Merck cancer-vaccine results.
• No fresh company-specific announcement was identified on August 19, 2026; recent quarterly news is not a new catalyst.
• The move therefore appears sector-driven rather than company-specific.